Renin Inhibitors

J Clin Hypertens (Greenwich). 2011;13:662–666. ©2011 Wiley Periodicals, Inc. KEY POINTS AND PRACTICAL RECOMMENDATIONS: •  Aliskiren, the sole oral renin inhibitor approved by the US Food and Drug Administration, is indicated for the treatment of hypertension, either as monotherapy or in combination,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Fisher, Naomi DL., Meagher, Emma A.
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2011
Matèries:
The American Society of Hypertension, Inc.: A Compendium of Antihypertensive Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108795/
https://ncbi.nlm.nih.gov/pubmed/21896147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00514.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars